Seeking Alpha

Eli Lilly & Co. (LLY)

()

News & PR
Market Currents

Buzz
Twitter: LLY

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Thursday Options Recap

Dec 10 • Frederic Ruffy • 2 Comments
Patent Worries Sting Eli Lilly

Dec 10 • optionMONSTER • Comment!
Eli Lilly: Solid Earnings on Deck for 2010

Dec 10 • Eddy Elfenbein • Comment!
8 HealthCare Stocks with 3%+ Dividends

Nov 29 • Hao Jin • 9 Comments
5 Good Dividend Plays

Nov 27 • Mark Riddix • 25 Comments
Seven Dividend Stocks to Take the Emotion Out of Investing

Nov 24 • Dividends4Life • 17 Comments
Diabetes Care: Global Investing Opportunities

Nov 22 • Mike Havrilla • 4 Comments
Competition in Blood - Thinners: Win - Win for Everyone Involved

Nov 20 • Derek Lowe • Comment!
Big Pharma Under Pressure as Drug Patents Expire and Pipeline Slows

Nov 19 • Research Recap • 1 Comment
Winning Investment Strategy: Focus on Value-Based Dividend Growth

Nov 18 • Dividends4Life • 5 Comments
The Real Price of Big Pharma's Huge Fines

Nov 10 • Derek Lowe • 6 Comments
Biotech Blooms at Eli Lilly

Nov 8 • The Burrill Report • 1 Comment
The Top 4 Healthcare Dividend Stocks: Covered Call Trades

Nov 6 • Double Dividend Stocks • 2 Comments
How Are the S&P's Dividend Aristocrats Performing?

Nov 5 • David I. Templeton • 8 Comments
Lilly Hopes New San Diego Facility Will Be 'a Biotechnology Powerhouse'

Nov 1 • The Burrill Report • Comment!
Determining Potential in Health Care Stocks

Oct 30 • J. Royden Ward • 4 Comments
Healthcare Profits: Assessing Company Sensitivity to Obamacare

Oct 30 • Richard Shaw • 11 Comments
8 Dividend Stocks with Wide Moats

Oct 21 • Dividends4Life • 33 Comments
Eli Lilly Q3: Beats Estimates, Raises Guidance

Oct 21 • Zacks.com • Comment!
Report from Europe: A Grounded Boeing to Drag Down the Dow?

Oct 21 • The Mole • 7 Comments
Wall Street Breakfast: Must-Know News

Oct 21 • SA Editor Eli Hoffmann • 7 Comments
Dividend Aristocrats: 3 to Watch

Oct 20 • Avi Morris • 13 Comments
Earnings Preview: Lilly

Oct 20 • theflyonthewall.com • Comment!
Incyte – Life After Debt (Part II)

Oct 19 • Ohad Hammer • Comment!
An Earnings Season Options Strategy

Oct 19 • Marco Hickey • 4 Comments
Health Care Stocks Selling for a Fraction of Their Worth

Oct 19 • Peter Mycroft Psaras • 5 Comments
Good Debt Coverage for Sustainable Dividends

Oct 14 • Dividend Growth Investor • 4 Comments
Investing in High-Yield Dividend Stocks

Oct 13 • Dividends4Life • 12 Comments
China Biotech Week in Review: Wyeth / Pfizer Merger Allowed

Oct 4 • ChinaBio Today • Comment!
Eli Lilly to Double China Workforce

Oct 2 • ChinaBio Today • 5 Comments
Eli Lilly Still Range-Bound Despite a Bet Otherwise

Oct 1 • optionMONSTER • 1 Comment
Why It's Not 1982 Again, Part 2

Sep 24 • William M. Wright • 16 Comments
Eli Lilly Braces for Reorganization Moves

Sep 15 • Derek Lowe • 2 Comments
Wall Street Prepares for Public Healthcare Reforms

Sep 15 • James Rickman • 3 Comments
Wall Street Breakfast: Must-Know News

Sep 15 • SA Editors • 11 Comments
Eli Lilly Announces 'Reorganization'

Sep 14 • Eddy Elfenbein • 1 Comment
Today's Closing Update: Slim Losses Barely Dent Week's Gains

Sep 11 • Midnight Trader • 10 Comments
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up

Sep 11 • Justin M. Hall • 23 Comments
30 High Dividend Stocks and ETFs

Sep 3 • Hao Jin • 10 Comments
Brilinta Data Should Soothe Some of AstraZeneca's Patent Cliff Woes

Sep 2 • EP Vantage • Comment!
Three Recent Biotech Activist Wins by Carl Icahn

Aug 31 • Michael Becker • 4 Comments

Eli Lilly & Co. (LLY)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers